Xcel Brands, Inc.
XELB News Today: Stay Updated with the Latest Xcel Brands, Inc. News in Real Time
Find XELB news now at Meyka AI. Stay informed with the latest Xcel Brands, Inc. stocks updates, including price news, market analysis, and expert insights.
William Blair Maintains Outperform on Bumble Inc. (BMBL) March 16, 2026
BMBL analyst rating: William Blair and Deutsche Bank maintained ratings on March 16, 2026; implications and Meyka grade B
H.C. Wainwright Maintains Buy on Savara Inc. (SVRA) March 2026
H.C. Wainwright maintains Buy on Savara Inc.; SVRA analyst rating held ahead of August PDUFA
AirSculpt (AIRS) NASDAQ +51% after 12b-25 filing 16 Mar 2026: earnings Mar 20
AIRS stock jumps after AirSculpt files 12b-25; we preview Mar 20 earnings and Meyka AI outlook
Leerink Maintains Outperform on Spyre Therapeutics, Inc. (SYRE) March 16, 2026
Leerink maintains Outperform on Spyre; SYRE analyst rating stays positive on March 16, 2026
Market closed: Almonty (AII.TO TSX) ahead of 19 Mar earnings: tungsten will set tone
AII.TO stock trades C$26.34 ahead of 19 Mar 2026 earnings; we review drivers, metrics and Meyka AI forecast
William Blair, Leerink Maintain Outperform on Structure Therapeutics (GPCR) Mar 2026
Two firms maintain Outperform on Structure Therapeutics; GPCR analyst rating stays positive after March 16, 2026 updates
Volume spike at Aerkomm Inc (AKOM.PA) EURONEXT 16 Mar 2026: watch liquidity
AKOM.PA stock jumps on volume spike to EUR 2.80; our volume-driven analysis and forecast for EURONEXT traders
Earnings pre-market 17 Mar 2026: CAICA DIGITAL (2315.T JPX) key metrics to watch
Pre-market earnings spotlight on 2315.T stock: CAICA DIGITAL reports 17 Mar 2026. Key metrics, valuation and Meyka AI forecast
Japan MHLW March 17: 2026 Fee Overhaul Prioritizes Drug Supply Stability
Japan MHLW 2026 medical fee overhaul shifts rewards to drug supply stability and leftover‑medicine cuts, raises co-pays on long-listed drugs, and changes pharmacy incentives that could reshape margins